G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2006
11/23/2006	WO2006122552A1 Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
11/23/2006	WO2006122450A1 Oral fluid rapid immunochromatography test
11/23/2006	WO2006122424A1 Protein depletion using volatile binding buffers
11/23/2006	WO2006122360A1 Assay device
11/23/2006	WO2006108130A3 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample
11/23/2006	WO2006108095A9 Serum biomarker for disease and methods of using same
11/23/2006	WO2006106340A3 Formation of aggregates in enzyme assays
11/23/2006	WO2006106115A3 Polypeptide marker for diagnosing alzheimer's disease
11/23/2006	WO2006103442A3 Materials and methods relating to breast cancer classification
11/23/2006	WO2006102333A3 Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex
11/23/2006	WO2006099191A3 Dual path immunoassay device
11/23/2006	WO2006097564A3 Novel soluble epcr protein of non-proteolytic origin and use thereof
11/23/2006	WO2006096861A9 METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs)
11/23/2006	WO2006096619A3 Stabilizing the activity of pqq-dependent glucose dehydrogenase in electrochemical biosensors
11/23/2006	WO2006094198A8 Surfaces coated with target-induced fluorescent compounds for detection of target elements
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006088362A3 Apparatus for transferring products
11/23/2006	WO2006085224A3 Modulation of cellular hypoxia responses through notch signalling
11/23/2006	WO2006084013A3 Semiconductor nanocrystal complexes and methods of detecting molecular interactions using same
11/23/2006	WO2006083932A3 Methods and compositions for aggregant detection
11/23/2006	WO2006083873A3 Screening and therapeutic methods for treating circadian rhythm disorders
11/23/2006	WO2006076296A3 A non-naturally occurring animal that expresses an untranslated non-coding rna
11/23/2006	WO2006072368A3 Probe for detecting nucleic acids
11/23/2006	WO2006069373A3 Diagnosis of preeclampsia
11/23/2006	WO2006060719A3 Use of endosialin binding proteins to isolate endosialin positive cells
11/23/2006	WO2006047450A3 Immunoassays for topiramate
11/23/2006	WO2006028565A3 Novel methods for high-throughput genome-wide location analysis
11/23/2006	WO2006015874B1 Method for diagnosing liver fibrosis
11/23/2006	WO2006005975B1 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof
11/23/2006	WO2005121778A3 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
11/23/2006	WO2005118885A9 Methods and apparatus for detection of viral infection
11/23/2006	WO2005116267A3 Emission ratiometric indicators of phosphorylation by c-kinase
11/23/2006	WO2005114176A3 Methods and systems for detecting hydrogen
11/23/2006	WO2005108991A3 Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter
11/23/2006	WO2005108623A3 Mn/ca ix/ ca9 and renal cancer prognosis
11/23/2006	WO2005101000A3 Human glycoprotein hormone superagonists and uses thereof
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	WO2005086744A3 Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
11/23/2006	WO2005070180A3 Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
11/23/2006	WO2005044292A3 Biomarkers of resistance to hiv-infections in humans and biological applications thereof
11/23/2006	WO2005001052A3 Modulation of apoptosis
11/23/2006	WO2004034012A3 Coded particles for multiplexed analysis of biological samples
11/23/2006	US20060265776 Viability
11/23/2006	US20060265764 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same
11/23/2006	US20060265763 Dyrks as modifiersof the apc and axin pathways and methods of use
11/23/2006	US20060265150 Method and apparatus for characterising multiphase fluid mixtures
11/23/2006	US20060265138 Expression profiling of tumours
11/23/2006	US20060265137 Methods to increase the capacity of high content cell-based screening assays
11/23/2006	US20060265134 Medicine management methods and apparatus
11/23/2006	US20060264617 Monoclonal antibodies to rna binding protein gw182
11/23/2006	US20060264610 Protein complexes of the tip60 transcriptional activator protein
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264517 Methods of reducing microbial resistance to drugs
11/23/2006	US20060264398 Purinergic modulation of smell
11/23/2006	US20060264393 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
11/23/2006	US20060264392 Modulators of angiogenesis
11/23/2006	US20060264366 Identifying an agent that inhibits binding of mammalian Mcl-1 with a human or mouse Mule polypeptide having a Mule BH3 domain by contacting the mixture with a candidate agent and detecting an agent-biased binding that is different from the reference binding, indicating that the agent is an inhibitor
11/23/2006	US20060264363 Inhibition of nerve cell death by inhibiting degradation of shc3, atf6 or crebl1 by htra2 and method of ameliorating neurodegenerative diseases
11/23/2006	US20060264362 Method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling
11/23/2006	US20060264361 Novel lysophosphatidic acid receptor
11/23/2006	US20060263908 Fluorescent complex, a fluorescent particle and a fluorescence detection method
11/23/2006	US20060263907 Fluorescence lateral flow immunoassay
11/23/2006	US20060263906 Tri-functional nanospheres
11/23/2006	US20060263905 Analyzing system, data processing apparatus, and storage medium
11/23/2006	US20060263904 Using lacquered membranes to screen for viruses, bacterial cells and spores in environmental samples
11/23/2006	US20060263900 Method and apparatus for rapid fat content determination
11/23/2006	US20060263897 Nanoparticles for detecting analytes
11/23/2006	US20060263894 Optical chemical sensing device with pyroelectric or piezoelectric transducer
11/23/2006	US20060263893 Method for determination of fuel thermal stability
11/23/2006	US20060263892 Detection of ortho-diamine residues in analytes containing residual cyclizing agents
11/23/2006	US20060263891 Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
11/23/2006	US20060263890 Portable probe used with ferrofluids to guide and steer particles or biolological cells contained within for separation, positioning,delivery and mixing; used in conjunction with a microscope, a micromanipulator, a catheter or endoscope
11/23/2006	US20060263889 One or more quaternary ammonium surfactants including tetraalkylammonium chloride or bromide and a ligand that forms a stable chromogen with hemoglobin, particularly 1,2-diaminocyclohexane or 3,6-dihyroxypyridazine
11/23/2006	US20060263888 Differential white blood count on a disposable card
11/23/2006	US20060263887 PGE-M as a biomarker of pulmonary inflammation
11/23/2006	US20060263886 Fluorous labeling for selective processing of biologically-derived samples
11/23/2006	US20060263884 Use of passageways through porous membranes
11/23/2006	US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006	US20060263874 Surface plasmon resonance (SPR) biosensor, which includes a transparent dielectric medium and thin film; attenuated total reflection in which a sensor unit for assay can be positioned reliably to prevent leakage of fluid in use of pipette devices
11/23/2006	US20060263871 Nucleic acid applification reaction station for disposable test devices
11/23/2006	US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006	US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
11/23/2006	US20060263852 Asp2
11/23/2006	US20060263841 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors
11/23/2006	US20060263837 Immunoassay system and method for detection of antigens
11/23/2006	US20060263836 Composition for homogeneous multiplexed microparticle-based assay
11/23/2006	US20060263835 autoantibodies which recognize extracellular structures of G protein-coupled receptors; autoimmune diseases; Raynaud's syndrome, cardiomyopathy, myocarditis, hypertension
11/23/2006	US20060263834 Functional multi-drug resistance assay
11/23/2006	US20060263833 System, method, and article for detecting abnormal cells using multi-dimensional analysis
11/23/2006	US20060263832 Patterning of centrosomes and centrosome fragments as templates for directed growth of microtubules
11/23/2006	US20060263831 Interfacial biomaterials for binding ceramic substrates
11/23/2006	US20060263830 Interfacial biomaterials
11/23/2006	US20060263829 Efficient haploid cell sorting flow cytometer systems
11/23/2006	US20060263828 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263826 Antibody protein analysis chip
11/23/2006	US20060263825 evaluating the hemagglutinin-binding components of saliva, that facilitate oral disease prediction; detectors and diagnostic kits
11/23/2006	US20060263824 Method for the use of information derived by the application of a probability law suitable for chiral selection and methods and systems employing same
11/23/2006	US20060263821 In vitro model for priocidal activity
11/23/2006	US20060263819 Diagnostics and therapeutics for macular degeneration-related disorders

1 ... 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 ... 3937